Company announcements · 2026-11-131 min read

Leqembi® Pen subcutaneous treatment launched in Japan

Plaaslike outomatiese vertaling · Oorspronklike brontaal

Illustration generated by Business News; it is not a source photograph.

Opsomming

STOCKHOLM, Nov. 13, 2026 — BioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai today announced that Leqembi Pen, the subcutaneous formulation of lecanemab, has been launched in Japan for the…

Oorspronklike brontaal: PR Newswire UK — News ReleasesLees oorspronklike →